Iterative Scopes
Iterative Health is a clinical trial site network connecting pharmaceutical sponsors and CROs with community-based GI, hepatology, obesity, and cardiology providers, using its SKOUT® AI tool to accelerate patient enrollment and site operations.
- Company typePrivate
- Founded2017
- HeadquartersCambridge, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Iterative Scopes does
Iterative Health, formerly known as Iterative Scopes, is a Cambridge, Massachusetts-based clinical research site network founded in 2017 that connects pharmaceutical sponsors and contract research organizations (CROs) with community-based healthcare providers running clinical trials. The company organizes its operations around four therapeutic focus areas: gastroenterology (GI), hepatology, obesity, and, following its May 2026 acquisition of NextStage Clinical Research's cardiology sites, cardiology. Iterative Health monetizes through professional services agreements in which it provides site activation, patient enrollment, and trial execution support to sponsors and CROs, while simultaneously enabling provider partners (such as GI Alliance, One GI, and US Heart & Vascular) to operate clinical research as a revenue line within their practices.
Iterative Scopes firmographics
Firmographics- Name
- Iterative Scopes
- Legal name
- Iterative Health
- Website
- https://iterativescopes.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Iterative Health is a clinical trial site network connecting pharmaceutical sponsors and CROs with community-based GI, hepatology, obesity, and cardiology providers, using its SKOUT® AI tool to accelerate patient enrollment and site operations.
- Ownership category
- akta.pro rank
Iterative Scopes industry classification
Industry- Product category
- Clinical Trial Site Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ), Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)
Keywords
Where Iterative Scopes is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Iterative Scopes business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Trial Site Services: Revenue generated from providing clinical trial site network services to pharmaceutical sponsors and CROs, including patient enrollment, site activation, and trial execution support for GI, Hepatology, Obesity, and Cardiology therapeutic areas.
- Patient Enrollment Services: Master services agreements with clinical trial sponsors to assist with patient enrollment for Phase 2 clinical trials, as evidenced by the Palisade Bio agreement.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Iterative Scopes product offering
Product offeringCore offering
Iterative Health (formerly Iterative Scopes) operates a global, performance-driven clinical trial site network embedded in community-based healthcare practices for GI, Hepatology, Obesity, and Cardiology therapeutic areas. The company provides pharmaceutical sponsors and CROs with site selection, site activation, patient enrollment, and trial execution services, while offering participating providers access to research studies, operational support, and AI-powered enrollment technology (SKOUT®).
Product overview
Iterative Health operates as a clinical research site network that connects sponsors and CROs with community-based healthcare providers. The company offers the SKOUT® product along with a global Site Network of research sites. They serve providers (helping them grow research ancillary with access to studies, operational support, and AI technology) and sponsors/CROs (providing site selection, activation speed, and patient enrollment). The company focuses on GI, Hepatology, Obesity, and Cardiology therapeutic areas.
Differentiator
Problem solved
Functional benefit
Brands
- SKOUT®: AI-powered tool referenced on the Iterative Health website under products section, aimed at helping sites and sponsors accelerate clinical trial operations.
Products and services
- SKOUT® SKOUT® is an AI-powered technology tool that helps clinical trial sites and sponsors accelerate patient enrollment and site operations with accuracy and precision.
- Iterative Health Site Network A global network of clinical trial research sites embedded in community care settings, connecting pharmaceutical sponsors and CROs with high-performing sites for GI, Hepatology, Obesity, and Cardiology trials, while providing participating providers with research ancillary growth opportunities.
Quantifiable outcome
- Double the patient enrollment rate compared to industry benchmarks
- +2 more outcomes
Companies that use Iterative Scopes
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Iterative Scopes technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Iterative Scopes partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- Palisade BiominorMaster services agreement with Palisade Bio to assist with patient enrollment for a Phase 2 clinical trial, supporting Palisade Bio's clinical development program.
- GI AlliancecoreStrategic partnership with GI Alliance, the leading gastroenterology practice management organization, to expand access to clinical trials across community-based GI practices and accelerate advancement of new therapies for patients.
- One GIcorePartnership with One GI to expand access to clinical trials across their network of GI practices, enabling patients in community settings to participate in clinical research.
- US Heart & Vascular (USHV)corePartnership with US Heart & Vascular to expand clinical trial access in the cardiology therapeutic area across their network of cardiovascular practices.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
Iterative Scopes competitors and assessment
Company assessmentDirect peers
- Elligo Health Research: Operates a 'Goes Direct' community-based clinical research site network that brings trials into physician practices, directly mirroring Iterative Health's embedded-in-community-care model. Comparable in serving sponsors/CROs with community-site infrastructure and tech-enabled enrollment.
- Circuit Clinical: Runs a network of community-based clinical trial sites and offers tech-enabled patient enrollment and trial operations services. Directly comparable as a mid-stage site network competitor with similar provider-embedded strategy.
Broad incumbents
- WCG (WIRB-Copernicus Group): Large clinical trial solutions provider offering IRB, technology, and site-support services used by sponsors and CROs. Overlaps with Iterative Health on site enablement, technology tools, and sponsor-facing clinical trial services, but at broader portfolio scale.
- IQVIA: World's largest CRO with extensive site network, clinical technology, and real-world evidence capabilities. Competes with Iterative Health for sponsor contracts and could expand community-site capacity internally to match the model.
- ICON plc: Global CRO providing site management, patient recruitment, and clinical operations across therapeutic areas. Comparable in offering sponsors full-service trial delivery including site-facing services.
- Labcorp Drug Development (Fortrea): Post-spin CRO from Labcorp offering clinical trial site services, central lab, and patient recruitment. Overlaps with Iterative Health on sponsor-facing site management and patient enrollment services.
- Medpace Holdings: Mid-cap CRO with strong site management and patient recruitment operations, particularly competitive in specialty therapeutic areas including gastroenterology and cardiology where Iterative Health focuses.
- Syneos Health: Biopharmaceutical services organization offering clinical development and site management solutions. Competes for sponsor trial placement and patient enrollment mandates across therapeutic areas.
Emerging players
- Science 37: Pioneer in decentralized clinical trial (DCT) technology and site-less trial operations. Adjacent threat: represents the alternative operating model that may reduce reliance on physical site networks like Iterative Health's.
- ObvioHealth: DCT platform providing virtual and hybrid trial execution for sponsors. Represents the structural shift toward decentralized models that could pressure community-site network economics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Iterative Scopes social profiles
Digital presenceIterative Scopes financial estimates
Financial estimateRevenue estimate
Valuation estimate
Iterative Scopes leadership team
Management profileNumber of profiles
Iterative Scopes subsidiaries and ownership
Company hierarchySubsidiaries1 record
Iterative Scopes funding detail
Funding detailFunding overview
Funding rounds17 records
Investors21 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Iterative Scopes M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Iterative Scopes
What does Iterative Scopes do?
Iterative Health (formerly Iterative Scopes) operates a global, performance-driven clinical trial site network embedded in community-based healthcare practices for GI, Hepatology, Obesity, and Cardiology therapeutic areas. The company provides pharmaceutical sponsors and CROs with site selection, site activation, patient enrollment, and trial execution services, while offering participating providers access to research studies, operational support, and AI-powered enrollment technology (SKOUT®).
Is Iterative Scopes a public or private company?
Iterative Scopes is a private company. It is classified as venture growth investor backed and is currently operating.
When was Iterative Scopes founded?
Iterative Scopes was founded in 2017. It employs 251 to 500 people.
Where is Iterative Scopes based?
Iterative Scopes is headquartered in Cambridge, United States, in the North America region.
How does Iterative Scopes make money?
Two revenue lines are on record. Clinical Trial Site Services are the primary driver. The others are patient Enrollment Services.
Who are Iterative Scopes's main competitors?
Direct peers on record are Elligo Health Research and Circuit Clinical. Broad incumbents are WCG (WIRB-Copernicus Group), IQVIA, ICON plc, Labcorp Drug Development (Fortrea), Medpace Holdings and Syneos Health. Emerging players are Science 37 and ObvioHealth.
Does Iterative Scopes have an API?
No public API is recorded for Iterative Scopes.
What industry is Iterative Scopes in?
Iterative Scopes's product category is Clinical Trial Site Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 54171 and its SIC code is 8731.